Roy Fleischmann
Roy Fleischmann publishes mostly in Rheumatology, Hematology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research and Spondyloarthritis Studies and Treatments.
- World rank
- #62,205 of 7,710,434 ranked researchers
- Rank in United States
- #23,961 of 1,627,098
- Works
- 490
- Citations
- 33k
- Citations per work
- 67.2
What does Roy Fleischmann research?
Roy Fleischmann's work is mostly in Medicine (71%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35071.4%
- Medicine35071.4%
- Everything else9819.9%
- Life Sciences438.7%
- 1Rheumatology47% of their works
- 2Hematology12% of their works
- 3Immunology9% of their works
- 4Genetics6% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
- Psoriasis: Treatment and Pathogenesis
- Lymphoma Diagnosis and Treatment
Which keywords describe Roy Fleischmann's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Ankylosing Spondylitis, Hemophagocytic Lymphohistiocytosis, Juvenile Idiopathic Arthritis, Spondyloarthritis and Rituximab.
- Lymphoma
- TH17 Cells
- Immunogenicity
- Genomic Aberrations
- Systemic Lupus Erythematosus
- Rituximab
- Juvenile Idiopathic Arthritis
- Ankylosing Spondylitis
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Hemophagocytic Lymphohistiocytosis
- Spondyloarthritis
- Antiphospholipid Syndrome
- Chronic Lymphocytic Leukemia
- Biosimilars
- IL-17
- Classification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies4572 topics
- Inflammation3721 topic
- Rheumatoid Arthritis3721 topic
- Ankylosing Spondylitis1711 topic
- Hemophagocytic Lymphohistiocytosis1711 topic
- Juvenile Idiopathic Arthritis1711 topic
- Spondyloarthritis1711 topic
- Rituximab1182 topics
- Antiphospholipid Syndrome851 topic
- Systemic Lupus Erythematosus851 topic
- Chronic Lymphocytic Leukemia761 topic
- Genomic Aberrations761 topic
- Biosimilars491 topic
- Immunogenicity491 topic
- IL-17431 topic
- TH17 Cells431 topic
- Classification421 topic
- Lymphoma421 topic
Where does Roy Fleischmann work?
Roy Fleischmann's main affiliation in the publication record is The University of Texas Southwestern Medical Center, United States.
How many publications and citations does Roy Fleischmann have?
OpenAlex counts 490 works and 32,928 citations for Roy Fleischmann, an h-index of 81, ranking #62,205 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Roy Fleischmann
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roy Fleischmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.